Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Saturday, January 10, 2015

India: HCV infection in hemodialysis patients raises concerns

AURANGABAD: Hepatitis C virus (HCV) infection which is an important pathogen causing liver disease is becoming a major public health problem, with an estimated 25% to 40% prevalence in India. Raising concern over the issue, experts said patients on multiple blood transfusions have a high risk for HCV due to the involvement of multiple routes of infections, especially poor blood screening of blood and low standard of dialysis procedures.

They were speaking at a workshop at Dattaji Bhale blood bank, organised by the Aurangabad Thalassemia Society to create awareness about thalassemia on Friday.

Mahendrasingh H Chauhan, medical director and in charge of the blood bank said that high prevalence of Hepatitis C virus (HCV) has been reported among dialysis patients throughout the world. Serious efforts need to be taken to investigate HCV in patients undergoing hemodialysis (HD) treatment who are at great risk to HCV infection.

Read more...

No comments:

Post a Comment